These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7200161)

  • 1. Hemodynamic effects of prostaglandin E1 during cardiopulmonary bypass in infants and children.
    Kawamura M; Minamikawa O; Yokochi H; Maki S; Yasuda T; Mizukawa Y
    Jpn J Surg; 1982; 12(1):19-25. PubMed ID: 7200161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic side effects of prostaglandin E1 in patients before and during cardiopulmonary bypass.
    Karliczek G; van den Dungen JJ; Brenken U; Eijsman L; Kootstra GJ; Homan van der Heide JN; Wildevuur CR
    Thorac Cardiovasc Surg; 1981 Feb; 29(1):55-9. PubMed ID: 6164120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of prostaglandin E1 in patients undergoing clinical cardiopulmonary bypass.
    van den Dungen JJ; Karliczek GF; Brenken U; van der Heide JN; Wildevuur CR
    Ann Thorac Surg; 1983 Apr; 35(4):406-14. PubMed ID: 6682305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects and arterial concentration of prostaglandin E1 during cardiopulmonary bypass.
    Okuda M; Faruhashi K; Konishi K; Muneyuki M
    Eur J Anaesthesiol; 1991 Mar; 8(2):129-34. PubMed ID: 1874208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hemodynamic effects of phenoxybenzamine in neonates, infants, and children.
    Mossad E; Motta P; Sehmbey K; Toscana D
    J Clin Anesth; 2008 Mar; 20(2):94-8. PubMed ID: 18410862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful weaning from cardiopulmonary bypass with central venous prostaglandin E1 and left atrial norepinephrine infusion in patients with acute pulmonary hypertension.
    Tritapepe L; Voci P; Cogliati AA; Pasotti E; Papalia U; Menichetti A
    Crit Care Med; 1999 Oct; 27(10):2180-3. PubMed ID: 10548203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of prostaglandin E1 infusion during cardiopulmonary bypass].
    Okuda M; Ohi Y; Utsunomiya H; Kurata M; Konishi K; Muneyuki M
    Masui; 1989 Aug; 38(8):1036-41. PubMed ID: 2810697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-anti-aggregating and hemodynamic effects of adenosine and prostaglandin E1.
    Masters TN; Born GV; Robicsek F
    Thorac Cardiovasc Surg; 1982 Feb; 30(1):14-20. PubMed ID: 6179225
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodynamic effects of prostaglandin E1 in patients with congenital heart disease and pulmonary hypertension.
    Weesner KM
    Cathet Cardiovasc Diagn; 1991 Sep; 24(1):10-5. PubMed ID: 1913785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of prostaglandin E1 and nitroprusside on pulmonary vascular resistance in children after open-heart surgery.
    Rubis LJ; Stephenson LW; Johnston MR; Nagaraj S; Edmunds LH
    Ann Thorac Surg; 1981 Dec; 32(6):563-70. PubMed ID: 7198428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of prostaglandin E1 on systemic and cerebral oxygenation before and during cardiopulmonary bypass].
    Kawahara F; Kadoi Y
    Masui; 2002 Feb; 51(2):128-33. PubMed ID: 11889777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of prostaglandin E1 and dibutyryl cyclic AMP on hemodynamics after cardiopulmonary bypass in valve replacement surgery].
    Sumiyoshi N; Kawachi S; Oishi K; Tsushima K; Nakatani T; Imanishi T; Matsuda M; Hirose T; Tagami D
    Masui; 1992 Apr; 41(4):532-8. PubMed ID: 1315879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic effects of prostaglandin E1 in patients with congenital heart disease and pulmonary hypertension].
    Pan S; Xiao M; Liu Y
    Zhonghua Wai Ke Za Zhi; 1996 May; 34(5):276-9. PubMed ID: 9387702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of prostaglandin E1 infusion in patients with acute myocardial infarction and left ventricular failure.
    Popat KD; Pitt B
    Am Heart J; 1982 Apr; 103(4 Pt 1):485-9. PubMed ID: 7199815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressed pulmonary removal of [3H]prostaglandin E1 after prolonged cardiopulmonary bypass.
    Pitt BR; Hammond GL; Gillis CN
    J Appl Physiol Respir Environ Exerc Physiol; 1982 Apr; 52(4):887-92. PubMed ID: 7200970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in pulmonary hypertension by prostaglandin E1 in decompensated chronic obstructive pulmonary disease.
    Naeije R; Mélot C; Mols P; Hallemans R
    Am Rev Respir Dis; 1982 Jan; 125(1):1-5. PubMed ID: 6802045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hypoxia on the hemodynamic actions of prostaglandin E1.
    Alpert JS; Beller GA; Giamber SR; Saltz SB
    Prostaglandins; 1976 May; 11(5):783-97. PubMed ID: 935511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of prostaglandin E1 infusion during cardiopulmonary bypass on cardiac and renal function in the early postoperative period].
    Sato K; Ebine K; Tamura S; Yokomuro M; Suzuki H; Kumabe S; Okuda T; Ootsuki M; Kosakai K
    Nihon Kyobu Geka Gakkai Zasshi; 1994 Mar; 42(3):360-5. PubMed ID: 8176292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiopulmonary actions of prostaglandin 6-keto-E1 in the anesthetized dog.
    Nandiwada P; Hyman AL; Feigen LP; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1980 May; 245(1):118-28. PubMed ID: 7190813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.